Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000919574-19-004698
Filing Date
2019-07-19
Accepted
2019-07-19 16:01:45
Documents
1

Document Format Files

Seq Description Document Type Size
1 d8342170_13-g.htm SC 13G 180583
  Complete submission text file 0000919574-19-004698.txt   182250
Mailing Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Subject) CIK: 0001061027 (see all company filings)

EIN.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-81034 | Film No.: 19963476
SIC: 2834 Pharmaceutical Preparations

Mailing Address 731 ALEXANDER ROAD BUILDING 2, SUITE 500 PRINCETON NJ 08540
Business Address 731 ALEXANDER ROAD BUILDING 2, SUITE 500 PRINCETON NJ 08540 609-419-1800
CAXTON CORP (Filed by) CIK: 0001388551 (see all company filings)

EIN.: 222437619 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G